Journal
EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 949, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.ejphar.2023.175730
Keywords
Dulaglutide; Sepsis; Lung injury; Inflammation; Apoptosis
Categories
Ask authors/readers for more resources
This study investigated the effects and mechanism of action of dulaglutide in lipopolysaccharide-induced lung injury in mice with sepsis. The results showed that dulaglutide improved weight loss, reduced lung injury, reversed the increase in inflammatory cytokine expression, and reduced the infiltration of immune cells in the lung tissues. Additionally, dulaglutide reduced the expression of STAT3 and NLRP3, suggesting their potential as therapeutic targets for sepsis-induced lung injury.
Sepsis is a dangerous condition with a high mortality rate. In addition to promoting insulin secretion in a glucose -dependent manner, glucagon-like peptide-1 (GLP-1) also exhibits anti-inflammatory properties. Dulaglutide is a glucagon-like peptide-1 receptor agonist (GLP-1 RA). In this study, we investigated the effects and mechanism of action of dulaglutide (Dul) in lipopolysaccharide (LPS) induced lung injury in mice with sepsis. In mice with LPS (15 mg/kg, ip, qd)-induced acute lung injury, the administration of dulaglutide (0.6 mg/kg, ip, qd) improved weight loss, reduced lung injury, reversed the increase in IL-1 beta, TNF-alpha, IL-6, CXCL1, CCL2 and CXCL2 expression in the lung, and reduced the infiltration of neutrophils and macrophages in the lung tissues. The decline in caspase-3, cleaved caspase-3, caspase-8, and Bcl-2/Bax expression and the increase in the number of TUNEL positive cells in the lung were reversed, suggesting that GLP-1RA could play a protective role in the lung by inhibiting inflammation and apoptosis. In addition, GLP-1RA could reduce the expression of P-STAT3 and NLRP3, suggesting that P-STAT3 and NLRP3 may be potential targets against lung injury in sepsis. Collectively, our data demonstrated that GLP-1RA exerts a protective effect against sepsis-induced lung injury through mechanisms related to the inhibition of inflammation, apoptosis, and STAT3 signaling.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available